| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $381.21M | - | |
| Other | 278.6K | $45.41M | - | |
| Other | 232.5K | $37.89M | - | |
| COO | 119.9K | $19.54M | - | |
| ? | 96.6K | $15.74M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2025 | Anders Jack47 | Chief Financial Officer | Sell | 2,170 | $39.83 | $86,431.10 | -1.9% | +16.2% | +293.7% | |
| Jun 16, 2025 | Kelsey Stephen Michael46 | See Remarks | Sell | 4,289 | $39.83 | $170,830.87 | -1.5% | +16.2% | +293.7% | |
| Jun 16, 2025 | Wei Lin | Chief Medical Officer | Sell | 2,173 | $39.83 | $86,550.59 | -2.3% | +16.2% | +293.7% | |
| Mar 20, 2025 | Cislini Jeff | General Counsel | Sell | 2,041 | $38.71 | $79,008.13 | -3.4% | +3.7% | +148.8% | |
| Mar 17, 2025 | Cislini Jeff | General Counsel | Sell | 1,458 | $39.04 | $56,920.76 | -2.4% | +1.6% | +153.3% | |
| Mar 17, 2025 | Goldsmith Mark A52 | See Remarks | Sell | 11,738 | $39.04 | $458,255.04 | -2.6% | +1.6% | +153.3% | |
| Mar 17, 2025 | Anders Jack47 | Chief Financial Officer | Sell | 1,864 | $39.04 | $72,771.12 | -1.6% | +1.6% | +153.3% | |
| Mar 17, 2025 | Kelsey Stephen Michael46 | See Remarks | Sell | 3,294 | $39.04 | $128,598.75 | -1.1% | +1.6% | +153.3% | |
| Mar 17, 2025 | Horn Margaret A48 | Chief Operating Officer | Sell | 3,058 | $39.04 | $119,385.24 | -2.0% | +1.6% | +153.3% | |
| Jan 21, 2025 | Cislini Jeff | General Counsel | Sell | 2,406 | $40.50 | $97,443.00 | -5.8% | -9.0% | +192.7% |